{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:12:16Z","timestamp":1786119136793,"version":"build-2736575974"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1097\/rlu.0b013e318148b1dd","type":"journal-article","created":{"date-parts":[[2009,3,4]],"date-time":"2009-03-04T17:26:43Z","timestamp":1236187603000},"page":"765-769","source":"Crossref","is-referenced-by-count":16,"title":["Atypical Paget's Disease With Quantitative Assessment of Tracer Kinetics"],"prefix":"10.1097","volume":"32","author":[{"given":"Gopinath","family":"Gnanasegaran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia E.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glen M.","family":"Blake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Vijayanathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan E.","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignac","family":"Fogelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-1-20210204","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1093\/rheumatology\/keh243","article-title":"Management of Paget's disease of bone.","volume":"43","author":"Langston","year":"2004","journal-title":"Rheumatology"},{"key":"R2-1-20210204","first-page":"41","article-title":"Pathophysiology and Treatment of Paget's Disease of Bone. 1st ed.","author":"Kanis","year":"1992"},{"key":"R3-1-20210204","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1359\/jbmr.2000.15.12.2315","article-title":"A negative search for a paramyxoviral etiology of Paget's disease of bone: molecular, immunological, and ultrastructural studies in U.K. patients.","volume":"15","author":"Helfrich","year":"2000","journal-title":"J Bone Miner Res"},{"key":"R4-1-20210204","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1359\/jbmr.2002.17.1.145","article-title":"Sequence analysis of measles virus nucleocapsid transcripts in patients with Paget's disease.","volume":"17","author":"Friedrichs","year":"2002","journal-title":"J Bone Miner Res"},{"key":"R5-1-20210204","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1359\/jbmr.2002.17.12.2290","article-title":"The pro and con of measles virus in Paget's disease.","volume":"17","author":"Rima","year":"2002","journal-title":"J Bone Miner Res"},{"key":"R6-1-20210204","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S8756-3282(02)00833-5","article-title":"Paget's disease of bone in Lancashire and arsenic pesticide in cotton mill wastewater: a speculative hypothesis.","volume":"31","author":"Lever","year":"2002","journal-title":"Bone"},{"key":"R7-1-20210204","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/0049-0172(94)90037-X","article-title":"Epidemiological aspects of Paget's disease: family history and relationship to other medical conditions.","volume":"23","author":"Siris","year":"1994","journal-title":"Semin Arthritis Rheum"},{"key":"R8-1-20210204","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1093\/hmg\/11.20.2385","article-title":"Molecular genetics of too much bone.","volume":"11","author":"Janssens","year":"2002","journal-title":"Hum Mol Genet"},{"key":"R9-1-20210204","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S8756-3282(02)00817-7","article-title":"Guidelines on the management of Paget's disease of bone.","volume":"31","author":"Selby","year":"2002","journal-title":"Bone"},{"key":"R10-1-20210204","first-page":"127","article-title":"Paget's disease of bone. Diagnosis and indications for treatment.","volume":"33","author":"Kotowicz","year":"2004","journal-title":"Aust Fam Physician"},{"key":"R11-1-20210204","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1359\/jbmr.2002.17.3.465","article-title":"Incidence and natural history of Paget's disease of bone in England and Wales.","volume":"17","author":"van Staa","year":"2002","journal-title":"J Bone Miner Res"},{"key":"R12-1-20210204","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1093\/rheumatology\/34.11.1061","article-title":"Osteoarthritis and Paget's disease.","volume":"34","author":"Helliwell","year":"1995","journal-title":"Br J Rheumatol"},{"key":"R13-1-20210204","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-4608(03)00105-5","article-title":"Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: osteosarcoma and related tumors.","volume":"145","author":"Sandberg","year":"2003","journal-title":"Cancer Genet Cytogenet"},{"key":"R14-1-20210204","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S0140-6736(80)91496-8","article-title":"Effect of dichloromethylene diphosphonate in Paget's disease of bone and in hypercalcaemia due to primary hyperparathyroidism or malignant disease.","volume":"1","author":"Douglas","year":"1980","journal-title":"Lancet"},{"key":"R15-1-20210204","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1002\/art.1780231008","article-title":"Musculoskeletal manifestations of Paget's disease of bone.","volume":"23","author":"Altman","year":"1980","journal-title":"Arthritis Rheum"},{"key":"R16-1-20210204","first-page":"581","article-title":"Validation of a method of a blood-sampling method for the measurement of 99mTc-Methylene diphosphonate skeletal plasma clearance.","volume":"47","author":"Moore","year":"2006","journal-title":"J Nucl Med"},{"key":"R17-1-20210204","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/BF02031975","article-title":"Coexisting ankylosing spondylitis and Paget's disease.","volume":"9","author":"Olivieri","year":"1990","journal-title":"Clin Rheumatol"},{"key":"R18-1-20210204","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1093\/rheumatology\/35.10.1011","article-title":"Paget's disease in a patient with ankylosing spondylitis\u2014a diagnostic dilemma.","volume":"35","author":"Peel","year":"1996","journal-title":"Br J Rheumatol"},{"key":"R19-1-20210204","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1097\/00003072-199910000-00027","article-title":"Atypical presentation of Paget's disease on bone scintigraphy.","volume":"24","author":"Minshew","year":"1999","journal-title":"Clin Nucl Med"},{"key":"R20-1-20210204","first-page":"S269","article-title":"Risedronate vs etidronate: durable remission with only two months of 30 mg risedronate.","volume":"12","author":"Miller","year":"1997","journal-title":"J Miner Res"},{"key":"R21-1-20210204","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1359\/jbmr.1998.13.6.1032","article-title":"Risedronate in the treatment of Paget's disease: an open-label, multicenter study.","volume":"13","author":"Siris","year":"1998","journal-title":"J Bone Miner Res"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00003072-200710000-00001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:39:20Z","timestamp":1786037960000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00003072-200710000-00001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":21,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0b013e318148b1dd","relation":{},"ISSN":["0363-9762"],"issn-type":[{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10]]}}}